Moderna aims to deliver Omicron COVID-19 vaccine by September

27 January 2022 - A COVID-19 booster shot, targeted specifically at the Omicron variant, is expected to be delivered by ...

Read more →

Shortage of prescription infant formula worries parents

28 January 2022 - A shortage of prescription infant formula has parents worried about how they will feed their babies. ...

Read more →

Novavax COVID-19 vaccine to be available in coming weeks

24 January 2022 - Australians aged 18+ will now have access to a fourth COVID-19 vaccine, Nuvaxovid (Novavax) in coming weeks, ...

Read more →

Pharmacists struggle to meet demand for free COVID test kits amid stock shortage

23 January 2022 - Chemists across the country say they do not have enough rapid antigen tests to start handing ...

Read more →

Extension to image based prescription special arrangement

22 December 2021 - The Department of Health has extended the ‘image based prescription’ interim measure which allows the supply of ...

Read more →

mRNA manufacturing facility will deliver long term health benefits for Australians

14 December 2021 - Medicines Australia welcomes the announcement that Australia will manufacture mRNA vaccines in a deal struck with ...

Read more →

Moderna vaccine deal to produce 100 million doses in Melbourne reached by Federal and Victorian Governments

13 December 2021 - Australia is poised to become the largest producer of mRNA vac­cines outside the US and Europe ...

Read more →

ACCC helps to protect Australians against medicine shortages caused by COVID-19

10 December 2021 - Medicine shortages from the COVID-19 pandemic will continue to be actively managed by Medicines Australia and ...

Read more →

PHARMAC negotiates deal with Pfizer for its promising new oral antiviral treatment for COVID-19

6 December 2021 - PHARMAC has negotiated an agreement with Pfizer for its promising new oral anti-viral treatment to treat ...

Read more →

Pfizer to provide U.S. Government with 10 million treatments courses of investigational oral antiviral candidate to help combat COVID-19

18 November 2021 - If approved or authorised, Paxlovid (PF-07321332; ritonavir) would be the first oral anti-viral of its kind, a ...

Read more →

Valneva receives EU deal for COVID jab, and seeks apology from UK

11 November 2021 - French vaccine manufacturer, Valneva, has announced that it has won EU approval to supply up to 60 ...

Read more →

Merck and Ridgeback announce Japanese Government to purchase 1.6 million courses of molnupiravir, an investigational oral COVID-19 anti-viral medicine, upon authorisation or approval

10 November 2021 - Merck and Ridgeback Biotherapeutics today announced that the Japanese government will purchase, upon authorization or approval, approximately ...

Read more →

WHO warns of massive syringe shortfall in 2022

10 November 2021 - There could be a shortage of up to two billion syringes in 2022 with billions more than ...

Read more →

Merck and Ridgeback announce U.S. Government to purchase 1.4 million additional courses of molnupiravir, an investigational oral anti-viral medicine, for the treatment of mild to moderate COVID-19 in at risk adults

9 November 2021 - Merck and Ridgeback Biotherapeutics today announced that the United States Government will exercise two of its options ...

Read more →

COVID-19: PHARMAC confident with growing stock of drugs to treat virus

7 November 2021 - PHARMAC is growing increasingly confident it is getting close to having enough of the drugs needed to ...

Read more →